We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.

Zacks Special Report

5 Stocks Set To Double

Five Zacks experts each predict their favorite single stock to gain +100% or more in the months ahead. We can't guarantee future performance, but previous editions of this Special Report have racked up some huge gains.

Today, be among the first to see our just-released picks for Free.

By submitting your email, you’ll also get a free Profit from the Pros membership, which highlights exclusive market updates and daily Strong Buy stocks. You can unsubscribe at any time.

Each stock is the personal favorite of a noted Zacks Expert.

Stock #1: Disruptive Fintech Partnering with Retail Giants
Analysts have significantly increased this firm's earnings estimates and price targets have jumped dramatically. With a focus on new revenue streams and expanding partnerships with major retailers, this is a compelling play for investors looking for outsized profit potential.

Stock #2: Junior Miner Surging on Record-High Gold Prices
Gold prices are up big, but this overlooked mining stock is poised for even greater upside. A combination of strong fundamentals, promising technical indicators and ideal economic conditions have created a powerful uptrend for investors to capitalize on.

Stock #3: Dominant Internet Stock Gained +185% — Now Set to Double Again
675 million people used this online platform last year, and a newly-announced partnership with a brick-and-mortar titan adds a massive opportunity to increase profits. Shares could easily double as sales and earnings skyrocket.

Stock #4: Healthcare Company at the Forefront of 2 Megatrends
This company grew annual sales from $150 million in 2020 to over $1 billion today, and the momentum shows no signs of stopping. This top-line expansion highlights the company's ability to capitalize on two of healthcare's fastest growing arenas.

Stock #5: Cutting-Edge Biotech Developing Next-Gen Obesity Drug
Little-known drugmaker is tapping into the $130 billion market for obesity drugs. Analysts set price targets +128% above current levels. It's also a prime buyout target, where a Big Pharma firm may pay a triple-digit premium to grab the company's proprietary technology.